Molecular Biomarkers in Radiotherapy of Cervical Cancer A collaboration project between Department of Gynecologic Oncology and Department of Radiation.
Validation of Predictive Classifiers Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute .
NorCal SOT Fall Symposium: New Frontiers in Oncology Drug Development September 27, 2012 Jocelyn Holash Novartis Institutes for Biomedical Research Preclinical.
Value of Chemoresistant Testing for Cancer Treatment Dr. Kai Schulze-Forster.
Università degli Studi di Palermo DIPARTIMENTO DI ONCOLOGIA SEZIONE DI ONCOLOGIA MEDICA (Dir. Prof. Nicola Gebbia) Surrogate biomarkers in evaluating response.
LUNG CANCER OMICS VLADIMIR LAZAR MD, PhD Director of IGR’s Genomic Centre and Integrated biology platform [email protected] 2 nd,Quebec conference.
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
LUNG CANCER OMICS
Application of Molecular Medicine towards personalised treatment in Oncology. Dr Godfrey Grech University of Malta Editor of book (July 2015) entitled.
GEFITINIB IN ESOPHAGEAL CANCER: JUST THE BEGINNING OF A SPICY STORY
Biomarker and Classifier Selection in Diverse Genetic Datasets J AMES L INDSAY 1 E D H EMPHILL 2 C HIH L EE 1 I ON M ANDOIU 1 C RAIG N ELSON 2 U NIVERSITY.
The gap between biomarkers and surrogate endpoints Oncology